Everest Medicines Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-658.75	-1,041	-844.46	-247.28	-1,009	-5,658
Depreciation & Amortization	151.94	128.62	72.75	40.23	30.76	20.4
Other Amortization	5	5	4.03	2.55	0.37	10.05
Loss (Gain) From Sale of Assets	0.03	-	1.43	-1,320	-	-
Asset Writedown & Restructuring Costs	-	356.34	51.97	16.49	-	-
Loss (Gain) From Sale of Investments	0.01	0.01	-0.85	21.75	-	-
Stock-Based Compensation	103.32	91.1	73.42	206.5	224.98	117.27
Provision & Write-off of Bad Debts	0.17	0.22	-	-	-	-
Other Operating Activities	-53.55	-48.35	-46.19	153.15	-11.67	4,963
Change in Accounts Receivable	-41.68	-313.93	-44.64	-5.17	-0.05	-
Change in Inventory	17.03	2.86	-7.31	-11.19	-0.45	-
Change in Accounts Payable	66.23	106.69	-116.55	70.43	73.97	86.68
Change in Other Net Operating Assets	-35.78	33.32	87.22	-83.63	-39.13	-10.77
Operating Cash Flow	-446.04	-679.51	-769.19	-1,156	-729.94	-471.9
Capital Expenditures	-41.64	-65.41	-117.34	-355.92	-109.95	-8.6
Sale of Property, Plant & Equipment	-	-	0.06	0.31	-	-
Sale (Purchase) of Intangibles	-126.55	-138.75	1,432	488.17	-865.87	-511.33
Investment in Securities	1,083	1,179	-568.77	-1,161	-	-
Other Investing Activities	35.63	-	6.57	-	-	-
Investing Cash Flow	950.4	974.4	752.5	-1,028	-975.82	-519.93
Long-Term Debt Issued	-	70	451.46	-	-	348.59
Total Debt Issued	635.52	70	451.46	-	-	348.59
Long-Term Debt Repaid	-	-43.08	-463.2	-30.59	-23.66	-19.46
Net Debt Issued (Repaid)	155.93	26.92	-11.74	-30.59	-23.66	329.13
Issuance of Common Stock	58.13	30.56	29.79	5.28	5.86	3,387
Repurchase of Common Stock	-	-	-	-	-58.71	-
Other Financing Activities	-20.25	-19.68	-7.95	-	-	-10.05
Financing Cash Flow	193.81	37.8	10.1	-25.31	-76.51	5,638
Foreign Exchange Rate Adjustments	12.83	28.72	38.87	59.83	-58.81	-270.99
Net Cash Flow	710.99	361.41	32.28	-2,149	-1,841	4,375
Free Cash Flow	-487.68	-744.92	-886.53	-1,512	-839.89	-480.5
Free Cash Flow Margin	-57.29%	-105.41%	-703.97%	-11817.36%	-1555344.44%	-
Free Cash Flow Per Share	-1.51	-2.32	-2.83	-5.08	-2.86	-5.63
Cash Interest Paid	20.25	19.68	7.95	-	-	-
Levered Free Cash Flow	-	-689.6	2,356	-2,031	-1,339	-857.73
Unlevered Free Cash Flow	-	-675.73	2,371	-2,028	-1,336	-836.57
Change in Working Capital	5.8	-171.07	-81.28	-29.56	34.35	75.91

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.